Related Experiment Video
Updated: Jun 10, 2026
Murine Renal Transplantation Procedure
Published on: July 10, 2009
CrmA gene transfer rescued CsA-induced renal cell apoptosis in graft kidney
Zheng Xiao1, Juan Shan, Chengwen Li
1Key Laboratory of Transplant Engineering and Immunology of Ministry Health of China, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan Province, PR China.
Abstract:
Cyclosporine A(CsA) causes significant nephrotoxicity that contribute to kidney graft loss in the long-term, it can induce cell apoptosis in renal cortex and medulla, reduce kidney function. The mechanisms are complex and involved in six apoptosis pathways including classical pathway, mitochondrial pathway, endoplasmic reticulum pathway, angiotensin II pathway, NO- and hypertonicity-related pathway. All these pathways may converge to a single way by activated Caspase-3, -6, -8, -9 and -12 that may become a potential new target for intervention. CrmA protein belonging to one of serine protease inhibitor family members, it widely inhibits the inflammatory Caspases and apoptotic Caspases and has a strong function on inhibiting apoptosis induced by many chemical inducers through effectively blocking Caspase-1, -3, -4, -5, -8, -9, and -10 enzymes. It is not reported if CrmA is resistant to apoptosis induced by immunosuppressant so far. Therefore we speculate CrmA can block down CsA-induced renal cell apoptosis through inhibiting the Caspase-3, -6, -8, -9 and -12 activated and further to eliminate CRD induced by CsA.
Insights
Cyclosporine A (CsA) causes kidney damage by inducing apoptosis. We speculate CrmA protein can inhibit this CsA-induced apoptosis by blocking key caspases, potentially protecting kidney function.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Cyclosporine A (CsA) is a potent immunosuppressant.
- CsA-induced nephrotoxicity is a major cause of kidney graft loss.
- CsA triggers renal cell apoptosis through multiple complex pathways.
Purpose of the Study:
- To investigate the potential of CrmA protein as a therapeutic agent against CsA-induced nephrotoxicity.
- To explore the mechanism by which CrmA might inhibit CsA-induced apoptosis in renal cells.
Main Methods:
- The study proposes a speculative mechanism based on existing knowledge of apoptosis pathways and CrmA function.
- Focuses on the convergence of CsA-induced apoptosis pathways to activated caspases.
- Highlights CrmA's known inhibitory effects on various caspases.
Main Results:
- CsA activates specific caspases (Caspase-3, -6, -8, -9, -12) contributing to renal cell apoptosis.
- CrmA protein is a known inhibitor of inflammatory and apoptotic caspases.
- It is hypothesized that CrmA can block CsA-induced apoptosis by inhibiting these activated caspases.
Conclusions:
- CrmA protein may offer a novel therapeutic strategy to mitigate CsA-induced nephrotoxicity.
- Inhibiting caspases via CrmA could prevent CsA-induced renal cell apoptosis and preserve kidney function.
- Further research is warranted to validate CrmA's efficacy against immunosuppressant-induced apoptosis.
